Explore the words cloud of the Dycare project. It provides you a very rough idea of what is the project "Dycare" about.
The following table provides information about the project.
BIO-SENSING SOLUTIONS SL
|Coordinator Country||Spain [ES]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
|Duration (year-month-day)||from 2016-06-01 to 2016-11-30|
Take a look of project's partnership.
|1||BIO-SENSING SOLUTIONS SL||ES (BARCELONA)||coordinator||50˙000.00|
The objective of Bio-Sensing Solution is to bring to the market a new ICT solution that improves quality of life for people suffering from musculoskeletal disorders. DyCare is a system for joint motion monitoring that enables clinicians to diagnose and manage their patients’ rehabilitation programs, accurately and affordably. There are 100 million people in Europe that can benefit from the DyCare system. Most clinicians today measure joint movement using rudimentary tools that are unreliable. Due to this, 60% of patients with musculoskeletal disorders are misdiagnosed and are prescribed ineffective rehabilitation programs that delay returning to an active, working life. DyCare will fix this healthcare system failure by delivering: reliable insights in real-time, a user-friendly cloud platform that tracks patient progress and recovery, and a portable system that works with new wearables. Our solution is truly unique in the market. Other available systems are cumbersome, require skilled personnel to operate, and are prohibitively expensive for most health centres. DyCare is a lightweight system, which will be sold at an affordable price, and is simple for both clinicians and patients to assess evolution and recovery. It will reduce diagnosis and treatment time, saving millions of Euros in healthcare costs and billions of Euros in lost work days. With the collaboration of Bayer, we are defining a distribution and commercialization strategy that will ensure rapid expansion into key European markets, eventually extending to North America and beyond. In Phase 1, we will carry out a feasibility study in order to demonstrate a DyCare Alpha version to key stakeholders, improve the product based on real user needs, obtain certifications and devise an IP protection strategy, define our commercialisation strategy and create a detailed business plan.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DYCARE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "DYCARE" are provided by the European Opendata Portal: CORDIS opendata.
CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical researchRead More
SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.Read More
Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneouslyRead More